TS Financial Group (TSFG)’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7K Hold
200
﹤0.01% 663
2026
Q1
$6K Hold
200
﹤0.01% 648
2025
Q4
$6K Hold
200
﹤0.01% 646
2025
Q3
$4K Hold
200
﹤0.01% 690
2025
Q2
$3K Hold
200
﹤0.01% 692
2025
Q1
$3K Hold
200
﹤0.01% 691
2024
Q4
$4K Hold
200
﹤0.01% 611
2024
Q3
$4K Hold
200
﹤0.01% 635
2024
Q2
$3K Hold
200
﹤0.01% 641
2024
Q1
$3K Hold
200
﹤0.01% 632
2023
Q4
$2K Hold
200
﹤0.01% 753
2023
Q3
$2K Hold
200
﹤0.01% 858
2023
Q2
$2K Hold
200
﹤0.01% 859
2023
Q1
$2K Hold
200
﹤0.01% 840
2022
Q4
$2K Hold
200
﹤0.01% 853
2022
Q3
$2K Hold
200
﹤0.01% 823
2022
Q2
$2K Hold
200
﹤0.01% 834
2022
Q1
$2K Hold
200
﹤0.01% 815
2021
Q4
$2K Hold
200
﹤0.01% 786
2021
Q3
$2K Hold
200
﹤0.01% 767
2021
Q2
$2K Hold
200
﹤0.01% 761
2021
Q1
$2K Sell
200
-14
-7% -$161 ﹤0.01% 690
2020
Q4
$2K Hold
214
﹤0.01% 765
2020
Q3
$2K Hold
214
﹤0.01% 691
2020
Q2
$3K Hold
214
﹤0.01% 600
2020
Q1
$2K Hold
214
﹤0.01% 612
2019
Q4
$2K Hold
214
﹤0.01% 648
2019
Q3
$1K Hold
214
﹤0.01% 761
2019
Q2
$2K Buy
214
+200
+1,429% +$2.41K ﹤0.01% 641
2019
Q1
$1K Buy
+14
New +$247 ﹤0.01% 737

Other funds holding TEVA

TS Financial Group (TSFG)'s TEVA Position: Q2 2026 in Review

TS Financial Group (TSFG) held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 200 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #663.

TS Financial Group (TSFG) first reported a position in TEVA in Q1 2019 and has held it in 30 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • TS Financial Group (TSFG) held 200 shares of Teva Pharmaceuticals worth $7K as of Q2 2026.
  • TS Financial Group (TSFG) left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of TS Financial Group (TSFG)'s portfolio in Q2 2026, its #663 holding.
  • TS Financial Group (TSFG) first reported a position in Teva Pharmaceuticals in Q1 2019 and has held it in 30 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on TS Financial Group (TSFG)'s 13F filing for Q2 2026, filed 23 Jul 2026.